Biologics market predicted to see 6.5% yearly growth in demand, spurred by new cancer and infectious disease therapies
The demand for biologics such as monoclonal antibodies and vaccines will continue to expand in the US during the next five years, according to predictions in a new industry report. The report, published by the Freedonia Group in Cleveland, Ohio, attributes the predicted annual 6.5 % growth in demand to advances in production technologies and an increasing number of novel disease targets. “The report analysis is consistent with what we see in market trends, but also in translational research trends,” says Terry Flotte, dean of the University of Massachusetts Medical School and acting head of MassBiologics, a University-associated nonprofit manufacturer … Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research